Gumapac, Erlinda B.

HRN: 27-64-41  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/18/2025
CEFTAZIDIME 1GM (VIAL)
08/18/2025
08/24/2025
IV
1g
Q8h
CAPMR
Remove - Pending Acceptance
08/18/2025
AZITHROMYCIN 500MG TABLET (TAB)
08/18/2025
08/22/2025
PO
500mg
Od
CAPMR
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: